Consulting Services to scope, staff, manage and deliver GxP solutions across North America, Europe and the Asia-Pacific. With over 12 years of experience meeting business-critical GxP needs for our partners, our network of technical experts will work with you to scope your requirements, identify key risks and opportunities, and agree on milestones for successful delivery. We believe that every challenge is unique, which is why we adopt a tailor-made solution for each engagement; creating a roadmap for delivery that is purpose-built to your specific needs. i-Pharm GxP meets all requirements in-house, eliminating complex supply chains and increasing value.
External link for i-Pharm GxP
1422 S Tryon St
Charlotte, North Carolina 28203, US
i-Pharm GxP reposted this
Want to know more about what we do? 🤔 Check out the document below to read a case study into one of our latest projects. We supported a leading Biotechnology company with the project management and CQV of a state-of-the-art 250,000 sq. ft. greenfield manufacturing facility for monoclonal antibody production. ______________ Got a project to scope in? Contact us today to find out how we can help with your business needs! #iPharmGxP #biotechnology #casestudy
Want to know more about what we do? 🤔 Check out the document below to read a case study into one of our latest projects. We supported a leading Biotechnology company with the project management and CQV of a state-of-the-art 250,000 sq. ft. greenfield manufacturing facility for monoclonal antibody production. ______________ Got a project to scope in? Contact us today to find out how we can help with your business needs! #iPharmGxP #biotechnology #casestudy
In which area does global collaboration have the biggest impact on drug development? 🤔 Last week, we put out a poll and asked for your opinion on global collaboration in drug development and the results are in! The growth of knowledge came out at number 1, with a majority of 57% of the votes. Global collaboration means that knowledge is shared across continents, leading to faster developments and a greater knowledge pool universally. _______________ Want to hear more on the subject? Tune in to our podcast where the team discussed this topic and more: 🔗 https://lnkd.in/epPWCX7p #iPharmGxP #globalcollaboration #drugdevelopment
Happy 4th of July! 🇺🇸 We are wishing all of of clients, candidates, friends and family a very Happy 4th of July celebration. We hope you have a wonderful day celebrating independence, filled with good company, great food, and plenty of fireworks. 🎆 The GxP Team. #4thjuly #iPharmGxP
How do we work with our clients? 🤔 Here's a case study from some recent work we did with a BioPharma firm. Take a look at the slides below to read about the project, the case, and the outcome from their partnership with i-Pharm GxP. _________________ Got a project to scope in? Contact us today to discuss how we can help develop your business! #iPharmGxP #BioPharma
International partnerships are reshaping the landscape of drug development in life sciences, supporting innovation across borders. 🤝 In our post yesterday, we looked at some of the key areas where global collaboration is making a key difference in the development of new treatments and medicines in life sciences. We identified enhanced clinical trials, the growth of knowledge, and the reduction of costs and risks to be the most impacted areas in drug development. Now with global collaboration on the rise, we want to hear from you, vote in our poll below and leave your thoughts in the comments. ⬇️ #lifesciences #drugdevelopment #iPharmGxP
This content isn’t available here
Access this content and more in the LinkedIn app
The need for international partnerships and cross-border teamwork has proven crucial to successful research and development in life sciences. But, how exactly does global collaboration impact drug development? We’ve had a look at some of the key areas where global collaboration is making a key difference in the development of new treatments and medicines in life sciences: 🧬 Enhanced clinical trials: Conducting clinical trials on a global scale provides access to a broader and more diverse patient population. This diversity helps develop treatments that are effective across different genetic backgrounds and demographics, ultimately leading to more inclusive and universally applicable therapies. 🤝 Growth of knowledge: International partnerships enable the sharing of knowledge and best practices across borders. By learning from each other’s successes and challenges, organisations can avoid common pitfalls, streamline processes, and adopt innovative approaches that have been proven effective elsewhere. 📉 Reduced costs and risks: By sharing financial and logistical burdens, companies can undertake more ambitious projects without bearing the full weight of potential failures alone. This collaborative approach makes it feasible to explore high-risk, high-reward research avenues. With global collaboration on the rise in our industry, where do you think this will have the biggest impact? Leave your thoughts in the comments below and stay tuned for a poll coming to our page soon! #lifesciences #globalcollaboration #iPharmGxP
The need for international partnerships and cross-border teamwork has proven crucial to successful research and development in life sciences. But, how exactly does global collaboration impact drug development? We’ve had a look at some of the key areas where global collaboration is making a key different in the development of new treatments and medicines in life sciences: 🧬 Enhanced clinical trials Conducting clinical trials on a global scale provides access to a broader and more diverse patient population. This diversity helps develop treatments that are effective across different genetic backgrounds and demographics, ultimately leading to more inclusive and universally applicable therapies. 🤝 Growth of knowledge International partnerships enable the sharing of knowledge and best practices across borders. By learning from each other’s successes and challenges, organisations can avoid common pitfalls, streamline processes, and adopt innovative approaches that have been proven effective elsewhere. 📉 Reduced costs and risks By sharing financial and logistical burdens, companies can undertake more ambitious projects without bearing the full weight of potential failures alone. This collaborative approach makes it feasible to explore high-risk, high-reward research avenues. With global collaboration on the rise in our industry, where do you think this will have the biggest impact? Leave your thoughts in the comments below and stay tuned for a poll coming to our page soon! #lifesciences #globalcollaboration #iPharmGxP
Episode 7 of the #GxPodcast 🚨 Here's Max Kelly talking to this month's guest Chris Lewis and the GxPodcast team about the rate of medical advancements, and the idea that the acceleration at which we see these advancements may one day overtake the process of aging itself. If you want to hear the rest of this interesting conversation, follow the link below to tune into the full episode. ⬇️ 🔗https://lnkd.in/exW4jkBB #medicaladvancement #iPharmGxP
We recently posted about the banning of noncompete agreements by the FTC and asked for your opinion on what this means for the life science industry. 🤔 With an even split at the top between the opening of more positions and an increase in hiring competition, and no votes for limited impact, we are excited to see how the industry adapts to this new ruling. _____________________ Contact us today to discuss how we can scope, staff, manage and deliver project solutions for your business: 🔗 https://lnkd.in/dS9x-f6K #iPharmGxP #noncompete